Trials / Unknown
UnknownNCT02777099
Impact of Remote Ischemic Postconditioning on Autonomic Function in Stroke Patients
Impact of Remote Ischemic Postconditioning on Autonomic Function and Prognosis in Clients With Acute Ischemic Stroke
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Guangzhou University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether remote ischemic postconditioning (RIPostC) initiates autonomic nervous system response and affects the prognosis in patients with acute ischemic stroke.
Detailed description
Remote ischemic postconditioning (RIPostC) has proven effective in reducing the ischemia-reperfusion injury. But the defensive mechanism of RIPostC still unclear. Stroke is frequently associated with autonomic dysfunction. Heart rate variability (HRV) represents the autonomic nervous system activity.This study aims to investigate whether RIPostC correlates with autonomic function and thus predicts prognosis of stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | remote ischemic postconditioning | Remote ischemic postconditioning was performed by 4 cycles of upper-limb ischemia and reperfusion.The upper-limb ischemia was induced by inflating a blood pressure cuff on a healthy upper arm to 200 mmHg for 5 min,and then deflating it for 5 min.Each patients in the PIPostC group will have the treatment once a day for 30 days. |
| PROCEDURE | sham remote ischemic postconditioning | Sham remote ischemic postconditioning was performed by 4 cycles of upper-limb ischemia and reperfusion. The upper-limb ischemia was induced by inflating a blood pressure cuff on a healthy upper arm to the patient's actual diastolic blood pressure for 5 min,and then deflating it for 5 min.Each patients in the sham PIPostC group will have the sham treatment once a day for 30 days. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-02-01
- Completion
- 2018-12-01
- First posted
- 2016-05-19
- Last updated
- 2017-09-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02777099. Inclusion in this directory is not an endorsement.